Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
U Schmidt-Erfurth, V Chong, A Loewenstein… - British Journal of …, 2014 - bjo.bmj.com
Age-related macular degeneration (AMD) is still referred to as the leading cause of severe
and irreversible visual loss world-wide. The disease has a profound effect on quality of life of …
and irreversible visual loss world-wide. The disease has a profound effect on quality of life of …
A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration
U Schmidt-Erfurth, SM Waldstein - Progress in Retinal and eye Research, 2016 - Elsevier
Neovascular age-related macular degeneration (AMD) has undergone substantial break-
throughs in diagnostic as well as therapeutic respect, with optical coherence tomography …
throughs in diagnostic as well as therapeutic respect, with optical coherence tomography …
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
Background/aims Real-life anti-vascular endothelial growth factor (VEGF) therapy use in
patients with wet age-related macular degeneration (wAMD) was assessed in a …
patients with wet age-related macular degeneration (wAMD) was assessed in a …
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
N Papadopoulos, J Martin, Q Ruan, A Rafique… - Angiogenesis, 2012 - Springer
Pharmacological inhibition of VEGF-A has proven to be effective in inhibiting angiogenesis
and vascular leak associated with cancers and various eye diseases. However, little …
and vascular leak associated with cancers and various eye diseases. However, little …
Defining response to anti-VEGF therapies in neovascular AMD
WM Amoaku, U Chakravarthy, R Gale, M Gavin… - Eye, 2015 - nature.com
The introduction of anti-vascular endothelial growth factor (anti-VEGF) has made significant
impact on the reduction of the visual loss due to neovascular age-related macular …
impact on the reduction of the visual loss due to neovascular age-related macular …
Age-related macular degeneration
Age-related macular degeneration is a major cause of blindness worldwide. With ageing
populations in many countries, more than 20% might have the disorder. Advanced age …
populations in many countries, more than 20% might have the disorder. Advanced age …
[HTML][HTML] Treat-and-extend versus monthly regimen in neovascular age-related macular degeneration: results with ranibizumab from the TREND study
Purpose To evaluate the efficacy and safety of ranibizumab 0.5 mg treat-and-extend (T&E)
versus monthly regimens in patients with neovascular age-related macular degeneration …
versus monthly regimens in patients with neovascular age-related macular degeneration …
Current and novel therapeutic approaches for treatment of neovascular age-related macular degeneration
RH ElSheikh, MZ Chauhan, AB Sallam - Biomolecules, 2022 - mdpi.com
Age-related macular degeneration AMD is one of the leading causes of blindness in the
elderly population. An advanced form of AMD known as neovascular AMD (nAMD) is …
elderly population. An advanced form of AMD known as neovascular AMD (nAMD) is …
[HTML][HTML] Quantitative analysis of OCT for neovascular age-related macular degeneration using deep learning
Purpose To apply a deep learning algorithm for automated, objective, and comprehensive
quantification of optical coherence tomography (OCT) scans to a large real-world dataset of …
quantification of optical coherence tomography (OCT) scans to a large real-world dataset of …
Safety and efficacy of anti-vascular endothelial growth factor therapies for neovascular age-related macular degeneration: a report by the American Academy of …
Purpose To review the evidence on the safety and efficacy of anti-vascular endothelial
growth factor (VEGF) therapies for the treatment of neovascular age-related macular …
growth factor (VEGF) therapies for the treatment of neovascular age-related macular …